CN114796383A - Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer - Google Patents
Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer Download PDFInfo
- Publication number
- CN114796383A CN114796383A CN202210406908.7A CN202210406908A CN114796383A CN 114796383 A CN114796383 A CN 114796383A CN 202210406908 A CN202210406908 A CN 202210406908A CN 114796383 A CN114796383 A CN 114796383A
- Authority
- CN
- China
- Prior art keywords
- stomach
- traditional chinese
- patients
- protecting powder
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 title claims abstract description 22
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 17
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 17
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 17
- 208000018556 stomach disease Diseases 0.000 claims abstract description 15
- 208000012895 Gastric disease Diseases 0.000 claims abstract description 3
- 229940079593 drug Drugs 0.000 claims description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 2
- 241000218176 Corydalis Species 0.000 claims description 2
- 240000000233 Melia azedarach Species 0.000 claims description 2
- 235000006533 astragalus Nutrition 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims 2
- 244000061520 Angelica archangelica Species 0.000 claims 1
- 241001061264 Astragalus Species 0.000 claims 1
- 235000001287 Guettarda speciosa Nutrition 0.000 claims 1
- 210000003038 endothelium Anatomy 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 claims 1
- 235000020610 powder formula Nutrition 0.000 claims 1
- 210000004233 talus Anatomy 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 210000001156 gastric mucosa Anatomy 0.000 abstract description 18
- 210000002784 stomach Anatomy 0.000 abstract description 18
- 208000004300 Atrophic Gastritis Diseases 0.000 abstract description 7
- 208000007882 Gastritis Diseases 0.000 abstract description 7
- 208000036495 Gastritis atrophic Diseases 0.000 abstract description 7
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 7
- 208000016644 chronic atrophic gastritis Diseases 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 7
- 201000005917 gastric ulcer Diseases 0.000 abstract description 7
- 206010017865 Gastritis erosive Diseases 0.000 abstract description 6
- 241000590002 Helicobacter pylori Species 0.000 abstract description 6
- 229940037467 helicobacter pylori Drugs 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 3
- 208000014674 injury Diseases 0.000 abstract description 3
- 206010006326 Breath odour Diseases 0.000 abstract description 2
- 208000032139 Halitosis Diseases 0.000 abstract description 2
- 206010020710 Hyperphagia Diseases 0.000 abstract description 2
- 239000002220 antihypertensive agent Substances 0.000 abstract description 2
- 229940127088 antihypertensive drug Drugs 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- 229940041181 antineoplastic drug Drugs 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 235000005686 eating Nutrition 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 235000020830 overeating Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 208000004232 Enteritis Diseases 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 208000000718 duodenal ulcer Diseases 0.000 abstract 1
- 230000009982 effect on human Effects 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000000689 peptic esophagitis Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 229960002986 dinoprostone Drugs 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a traditional Chinese medicine stomach-protecting powder for preventing stomach cancer. It can not only completely cure four refractory stomach diseases such as atrophic gastritis, erosive gastritis, helicobacter pylori and gastric ulcer which can be developed into gastric cancer, but also prevent gastric cancer; meanwhile, the traditional Chinese medicine composition has excellent prevention and treatment effects on patients with superficial gastritis, enteritis, reflux esophagitis, duodenal ulcer, gastric mucosa injury caused by frequent drinking, spicy and hot eating, overeating, frequent taking of antirheumatic drugs, antihypertensive drugs and anticancer drugs, and part of patients with halitosis. The stomach protecting powder belongs to nontoxic grade, and has no toxic or side effect on human, so the stomach protecting powder can be taken no matter how big or small people or the physique of patients, and the patients suffer from the gastropathy.
Description
(I) technical field
The invention relates to a traditional Chinese medicine stomach-protecting powder for preventing stomach cancer, which can cure various stomach diseases and prevent the occurrence of stomach cancer
The specific Chinese patent medicine belongs to a new medicine and a new technology for treating gastropathy and preventing gastric cancer.
(II) background of the invention
According to the survey of the world health organization of the united nations, more than 50 percent of people all over the world suffer from stomach diseases, the cancer mortality rate of the world is 25 percent of stomach cancer, and half of new cases of the stomach cancer all over the world come from China, so that the research and development of the specific traditional Chinese medicine for preventing the stomach cancer is urgent.
The medical scientist recognizes: there are many gastric diseases, but only four gastric diseases, atrophic gastritis, erosive gastritis, helicobacter pylori and gastric ulcer, can develop into gastric cancer. In other words, the four stomach diseases are cured, and the gastric cancer is prevented.
Disclosure of the invention
The tests of pharmacology, drug effect, toxicology and the like and a large number of clinical application experiments prove that the stomach-protecting powder is prepared in four years: the secret recipe medicine can thoroughly cure the four stomach diseases which cause the gastric cancer. The roots of the four diseases, such as atrophic gastritis, erosive gastritis, helicobacter pylori, gastric ulcer and the like, are that gastric mucosa is damaged in different degrees, and if the gastric mucosa is repaired, the four gastric diseases can be thoroughly cured.
The research of marine pharmacology experts proves that: calcium carbonate contained in cuttlebone in the stomach protecting powder can neutralize gastric acid, so that stimulation and damage of gastric acid to gastric mucosa at a focus can be reduced, and meanwhile, the stimulation and damage to gastric mucosa at a pathological part can be further reduced due to the change of the pH value of gastric content and the reduction of the activity of pepsin, and the gastric protecting powder is further beneficial to the repair of the gastric mucosa at the focus.
In addition, after the colloid contained in the cuttlebone reacts with organic matters in the stomach and gastric acid, a protective film can be formed on the gastric mucosa and the ulcer surface thereof, and the repair of the damaged gastric mucosa is facilitated. Meanwhile, experiments prove that: the cuttlebone can not only promote the synthesis of PGE2 of rat gastric mucosa, but also increase the synthesis of PGE2 of stress and acetic gastric ulcer model rat gastric mucosa, and the functions are both favorable for the protection and the repair of the gastric mucosa.
A large number of animal experiments and clinical experiments of tested human groups in the disease control center of Hunan province of the national authoritative testing organization also prove that the stomach-protecting powder has the effects of protecting and repairing the gastric mucosa of animals and human bodies. Therefore, the stomach protecting powder can thoroughly cure the four stomach diseases, namely, the stomach protecting powder can cure the root of the disease.
The animal experiment experimental group uses 2.5g/kg of stomach protecting powder and 1 percent of carboxymethyl cellulose to perfuse the stomach of a rat for 30 days continuously; the control group rats were gavaged with 1% carboxymethylcellulose for 30 consecutive days. On the day of experiment completion, both groups of rats were gavaged with 1 ml/rat of absolute alcohol, and then sacrificed for anatomical observation of lesions of gastric mucosal lesions as shown in the following table.
Total area of gastric mucosa hyperemia and diffuse bleeding (x + -s)
| Group of | Animal number (only) | Area (mm) 2 ) | P |
| Control group | 10 | 34.70±9.46 | …… |
| Experimental group | 10 | 21.70±7.18 | 0.009 |
The experiment proves that the stomach protecting powder has obvious protective effect on the damage of the gastric mucosa of animals
The human body test feeding experiment that the stomach protecting powder has the functions of protecting and repairing the damage of the gastric mucosa is to randomly divide voluntary subjects meeting the experiment standard into a test feeding group and a control group. The 'Jinhai stomach-protecting powder' and the placebo are respectively taken for 45 days according to the recommended dose, and after the experiment is finished, the result of the statistical treatment of each index data is as follows:
improvement of clinical symptoms
Gastroscopy gastric mucosa injury repair condition
The experiment proves that: the stomach protecting powder has obvious protection and repair functions on gastric mucosa of a human body.
The stomach-protecting powder is prepared from various traditional Chinese medicines, and has scientific formula, comprehensive action and multiple functions. In the formula, astragalus mongholicus, qi tonifying, yang rising, spleen tonifying, stomach invigorating, rhizoma cyperi, qi circulation promoting, spleen warming and stomach harmonizing, cuttlebone, chicken's gizzard-membrane, stomach invigorating, bleeding stopping, antacid and pain relieving, rhizoma corydalis, angelica dahurica, blood circulation promoting, pain relieving, qi regulating and middle warmer regulating, cassia twig, spleen warming, yang supporting, szechwan chinaberry fruit, qi circulation promoting, pain relieving, bulbus fritillariae cirrhosae, antacid and convulsion relieving, angelica sinensis, blood circulation promoting, bleeding stopping and pain relieving are matched with each other to realize synergistic interaction, so that the traditional Chinese medicine can treat both symptoms and root causes, and can stop medicine thoroughly after healing. Unlike some stomach medicines, it is not necessary to take the medicine for stomach pain and then take the medicine for stomach pain, which is the essential difference between stomach-protecting powder and other stomach medicines that are currently available.
Most of the stomach-protecting powder is a traditional Chinese medicine with homology of medicine and food, and a large number of animal experiments and clinical experiments in the disease control center of Hunan province verify that the Mingjin Haiwai stomach-protecting powder belongs to a nontoxic grade, so that the stomach-protecting powder can be taken by adults, children and patients regardless of constitutions, and is suitable for a large number of people.
The clinical application also finds that the stomach protecting powder can completely cure four stomach diseases of atrophic gastritis, erosive gastritis, helicobacter pylori and gastric ulcer which cause gastric cancer, and has excellent treatment and prevention effects on patients with gastric mucosa injury and part of halitosis caused by frequent drinking, eating spicy soup, overeating, frequent taking of anti-rheumatism drugs, anti-cancer drugs, antihypertensive drugs and the like.
(IV) detailed description
A large number of clinical applications prove that the total effective rate of the stomach protecting powder for treating the stomach diseases reaches over 96.2 percent.
The cure rate reaches more than 90 percent (40 patients in atrophic gastritis medical record group are continuously taken for 3-5 months, 38 patients are cured and 2 patients become non-atrophic gastritis after gastroscope review, 50 patients in erosive gastritis medical record group are cured and 48 patients are cured and 2 patients are obviously improved after gastroscope review for 2-3 months, 50 patients in gastric ulcer disease record group are cured and 2 patients are obviously improved and 1 patient is slightly improved after gastroscope review for 3 months, 40 patients in helicobacter pylori medical record group are continuously taken for 1-1.5 months, and 40 patients are all cured after c14 exhalation test),
for example, if a certain one of Shandong's king takes the stomach-protecting powder for one month, the four stomach diseases of atrophic gastritis, erosive gastritis, helicobacter pylori and gastric ulcer which are suffered by the powder can be completely cured.
Claims (2)
1. A traditional Chinese medicine stomach-protecting powder for preventing stomach cancer is characterized in that the stomach-protecting powder comprises the following components by weight: 150g of astragalus, 100g of rhizoma cyperi, 200g of endothelium corneum gigeriae galli, 200g of cuttlebone, 100g of angelica, 100g of bulbus fritillariae cirrhosae, 150g of rhizoma corydalis, 100g of szechwan chinaberry fruit, 100g of cassia twig and 150g of radix angelicae.
2. The traditional Chinese medicine stomach-protecting powder for preventing gastric cancer according to claim 1, characterized in that all the traditional Chinese medicines of all the formulas and the contents thereof in the stomach-protecting powder formula are mixed, crushed into fine powder, stirred evenly, filled into plastic packaging bags (5 g per bag) for packaging medicines, and sterilized; patients with gastropathy take the medicine 2 times daily, 1 bag with warm water each time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210406908.7A CN114796383A (en) | 2022-04-07 | 2022-04-07 | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210406908.7A CN114796383A (en) | 2022-04-07 | 2022-04-07 | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114796383A true CN114796383A (en) | 2022-07-29 |
Family
ID=82535924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210406908.7A Pending CN114796383A (en) | 2022-04-07 | 2022-04-07 | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114796383A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111729033A (en) * | 2020-04-21 | 2020-10-02 | 史玉林 | Specific traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
| CN113769013A (en) * | 2021-09-14 | 2021-12-10 | 史玉林 | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
-
2022
- 2022-04-07 CN CN202210406908.7A patent/CN114796383A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111729033A (en) * | 2020-04-21 | 2020-10-02 | 史玉林 | Specific traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
| CN113769013A (en) * | 2021-09-14 | 2021-12-10 | 史玉林 | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer |
Non-Patent Citations (1)
| Title |
|---|
| 王立新等: "扶正散结汤配合手术与化疗治疗消化系恶性肿瘤320例分析", 《中原医刊》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102641366A (en) | Traditional Chinese medicine composition for preventing and treating proventriculitis and gizzard erosion of poultry | |
| CN103405701A (en) | Medicine for treating gastrointestinal diseases and preparation method thereof | |
| CN102861193B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN111729033A (en) | Specific traditional Chinese medicine stomach-protecting powder for preventing stomach cancer | |
| CN104491220B (en) | A kind of traditional Chinese medicine composition for herpes | |
| CN113769013A (en) | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer | |
| CN105194341B (en) | The drug for treating xerostomia after head and neck neoplasm radiotherapy | |
| CN103933450A (en) | Traditional Chinese medicine composition for preventing or/and treating gastrointestinal diseases and preparation method of composition | |
| CN104274649B (en) | Medication for treating dental ulcer | |
| CN101543616A (en) | Traditional Chinese medicine composition for preventing and treating tumor and its preparation method | |
| CN114796383A (en) | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer | |
| CN101439149B (en) | Chinese medicinal composition for treating gastric ulcer, gastrorrhagia and gastric perforation | |
| CN110063977B (en) | Radix codonopsis and sea buckthorn composite electuary and application thereof | |
| CN112168913A (en) | Pure Chinese medicinal preparation capable of strengthening body and delaying aging and preparation method thereof | |
| CN110420292A (en) | A kind of Chinese medicine and preparation method thereof for treating headache | |
| CN101066318A (en) | Acne eliminating health product | |
| CN100450537C (en) | Chinese medicinal formulation for treating prostate hyperplasia | |
| CN105213780B (en) | A kind of Chinese medicine composition that treating chronic gastritis and its application | |
| CN102961662B (en) | Medicine for treating gastric ulcer and preparation method thereof | |
| CN115998817A (en) | Traditional Chinese medicine stomach-protecting powder for preventing stomach cancer | |
| CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof | |
| CN107174636A (en) | It is a kind of to treat Chinese medicine of rheumatic pain and preparation method thereof | |
| CN105663959A (en) | Traditional Chinese medicine preparation for nursing patient suffering from toothache and preparation method | |
| CN105194352A (en) | Traditional Chinese medicine composition capable of improving learning and memory abilities and preparation method thereof | |
| CN112402501A (en) | Oral medicine for treating gastritis and gastric ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220729 |
|
| WD01 | Invention patent application deemed withdrawn after publication |